ENTITY
Alnylam Pharmaceuticals

Alnylam Pharmaceuticals (ALNY US)

88
Analysis
Health Care • United States
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
more
•02 Feb 2015 14:48

The Matrix: A Strategist's roving thoughts: Swiss Francs, Europe, Alibaba

Key Call: STILL people are not catching up and/or doing the work on KVP’s high conviction long DollarSwissy call, I know, I know, it’s downright...

Share
bullish•Macroeconomics
•20 Jan 2015 22:51

The IMF's Patience with the ECB Wears Thin

The updated World Economic Outlook reveals that the IMF is (rightly) fed up with the ECB’s timid approach to monetary policy.  Monetary policy in...

Logo
507 Views
Share
•18 Jan 2015 11:04

Never Trust A Swiss Central Banker

Post SNB surprise announcement yesterday - after leading the market on as recently as a few weeks ago on – the term “Never trust a Swiss central...

Share
•09 Mar 2026 05:40

S&P500 March 2026 Forecast: VRT, COHR & SATS Leading the Pack

Announced additions: VRT, COHR, SATS and LITE. Following the announcement, all four are trading higher in after hours by 5.2%, 0.7%, 3.2%, and...

Share
bullish•Ciena Corp
•10 Feb 2026 08:42

Ciena Corp (CIEN US): Poised for S&P500 Inclusion Amid Price Surge and Dayforce Acquisition

CIEN replaced DAY in S&P500 migrating from MidCap at the close of 6 February with total passive fund volume of 30m shares and estimated net demand...

Share
x